BIOMAT Database Logo BIOMAT Database Logo

Maintenance intravesical bacillus calmette-guerin for superficial transitional cell carcinoma of bladder. A retrospective study. 1990

D M Schwalb, and J C Addonizio, and J Camilleri, and M S Choudhury, and M Eshghi
Department of Urology, New York Medical College, Valhalla.

Eighteen patients with recurrent and/or multifocal superficial transitional cell carcinoma of the bladder who were rendered tumor-free by transurethral resection and were then treated with either a single or second six-week course of induction Bacillus Calmette-Guerin (BCG) therapy, followed by maintenance therapy, were retrospectively reviewed. A 73 percent complete response rate was achieved in those patients treated prophylactically, while a 70 percent complete response rate was observed in patients treated for carcinoma in situ (CIS) with an average follow-up of twenty-nine months. Maintenance therapy may be warranted in those patients able to tolerate it without significant side effects.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

D M Schwalb, and J C Addonizio, and J Camilleri, and M S Choudhury, and M Eshghi
Bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder.
February 1986, The Journal of urology,
D M Schwalb, and J C Addonizio, and J Camilleri, and M S Choudhury, and M Eshghi
[Intravesical instillation of bacillus Calmette-Guerin for superficial bladder carcinoma: study on significance of additional maintenance instillations of bacillus Calmette-Guerin].
February 1991, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
D M Schwalb, and J C Addonizio, and J Camilleri, and M S Choudhury, and M Eshghi
Intravesical bacillus Calmette-Guerin in the treatment of superficial transitional cell carcinoma of the bladder.
August 1987, The Journal of urology,
D M Schwalb, and J C Addonizio, and J Camilleri, and M S Choudhury, and M Eshghi
Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
October 1986, The Journal of urology,
D M Schwalb, and J C Addonizio, and J Camilleri, and M S Choudhury, and M Eshghi
High grade superficial (G3t1) transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin (BCG).
December 2003, Journal of experimental & clinical cancer research : CR,
D M Schwalb, and J C Addonizio, and J Camilleri, and M S Choudhury, and M Eshghi
[Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer].
July 1994, Hinyokika kiyo. Acta urologica Japonica,
D M Schwalb, and J C Addonizio, and J Camilleri, and M S Choudhury, and M Eshghi
[The treatment of superficial bladder carcinoma with intravesical bacillus Calmette-Guerin].
May 1987, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
D M Schwalb, and J C Addonizio, and J Camilleri, and M S Choudhury, and M Eshghi
Re: Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
August 1987, The Journal of urology,
D M Schwalb, and J C Addonizio, and J Camilleri, and M S Choudhury, and M Eshghi
Small bladder and multiple urethral recurrences after intravesical instillation of bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder.
February 2001, The Journal of urology,
D M Schwalb, and J C Addonizio, and J Camilleri, and M S Choudhury, and M Eshghi
Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer.
April 1991, The Journal of urology,
Copied contents to your clipboard!